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Abstract: 
Curcumin is the yellow pigment of turmeric that interacts irreversibly forming an adduct with thioredoxin reductase (TrxR), an enzyme 
responsible for redox control of cell and defence against oxidative stress. Docking at both the active sites of TrxR was performed to compare 
the potency of three naturally occurring curcuminoids, namely curcumin, demethoxy curcumin and bis-demethoxy curcumin. Results show 
that active sites of TrxR occur at the junction of E and F chains. Volume and area of both cavities is predicted. It has been concluded by 
distance mapping of the most active conformations that Se atom of catalytic residue SeCYS498, is at a distance of 3.56 Å from C13 of 
demethoxy curcumin at the E chain active site, whereas C13 carbon atom forms adduct with Se atom of SeCys 498. We report that at least 
one methoxy group in curcuminoids is necessary for interation with catalytic residues of thioredoxin. Pharmacophore of both active sites of 
the TrxR receptor for curcumin and demethoxy curcumin molecules has been drawn and proposed for design and synthesis of most probable 
potent antiproliferative synthetic drugs. 
 
Background: 
Turmeric, a culinary food additive (spice) is powdered rhizome of 
the plant Curcuma longa. It has been used for centuries in 
indigenous medicine in India for the treatment of a variety of 
diseases. [1] The yellow pigment (curcuminoids), forming 3-4% by 
weight of turmeric is a mixture of curcumin (1, 94%) demethoxy 
curcumin (2, 6%) and bis-demethoxy curcumin (3, 0.3%) (Figure1). 
Aggarwal et al [2] have shown that curcumin is potent inhibitor of 
tumor initiation in vivo and in vitro studies. Many workers have 
shown that curcumin induces apoptosis and is a potent 
chemopreventive agent   in several cancers. e.g breast, colon , skin, 
oral, intestinal carcinogenesis. Fang et al [3]  characterized an 
irreversible inhibition mechanism of thioredoxin reductase (TrxR) 
by curcumin. Curcumin binds at the active site of thioredoxin 
reductase, and inhibits the process of electron transfer from NADPH 
to ribonucleotide TrxR is present in all living cells; but is 
overexpressed in tumor cells. However, tumor growth seems to be 
crucially dependent on an active thioredoxin redox system, making 
it a potential target for anticancer drugs.  
 
Thioredoxin is a key enzyme for DNA synthesis by directly serving 
as an electron donor to ribonucleotide reductase. TrxR is an 
important enzyme for DNA metabolism which is directly related to 
cell proliferation. Thioredoxin reductase (TrxR) catalyzes NADPH-
dependent reduction of the redox-active disulfide (S-S) in 
thioredoxin (Trx), which serves a wide range of functions in cellular 
proliferation, defense against oxidative stress, apoptosis and redox 
control. [4] The inhibition by curcumin and demethoxy derivatives 
was caused by covalent modification of active site CYS496 and 
SEC497 residues resulting in the destruction of the Trx reduction 
activity. In addition and more importantly, the curcumin-modified 
enzyme was converted into an NADPH oxidase with production of 
ROS to which cancer cells appear more sensitive. The three-
dimensional structure of the SeCYS498 mutant of rat TrxR in 
complex with NADP (+) has been determined to 3.0 Å resolution by 
X-ray crystallography. The overall structure is similar to that of 
glutathione reductase (GR), including conserved amino acid 
residues binding the cofactors FAD and NADPH. [5]  TrxR can 
serve as a potential target for anticancer drugs and curcumin has 
been reported to be a potent anticancer drug. The combination of 
these two factors motivated us for in silico study of three naturally 
occurring curcuminoids in terms of binding and docking energies 
which is likely to help in designing a new synthetic analog of 
curcumin as a potent anticancer drug. 
 
Methodology: 
The docking study was performed with three naturally occuring 
curcuminoids at the active site (CYS497-SEC498) of thioredoxin 
reductase. The PDB file that we considered for docking has S atom 
so we replaced it by Se atom with same coordinates because 
naturally occurring TrxR has SeCys498 amino acids. However, 
AutoDock does not recognize Se atom, which might be due to there 
is no parameter for Se atom in AutoDock. The grid maps were 
calculated with Auto Grid and grid’s size was decided accordingly 
and the volume calculated by CAST-p program. The dimensions of 
the grids for E chain cavity were thus 50 • 50 • 50 Å, with a spacing 
of 0.375 Å between the grid points and the center (30.074, 0.267 
and -1.792) close to the (S/Se) atom of the E chain of the catalytic 
residue CYS498. Similarly for F chain active site of TrxR, the 
center of catalytic residue CYS498 (S/Se) was used as the center 
(28.922, 7.243 and 42.311) of grid, with the grid points of 50 • 50 • 
50 Å and the spacing of 0.375 Å. AutoDock 3 with a genetic search 
algorithm was chosen for all dockings. The maximum number of 
energy evaluations, the maximum number of generation in the 
genetic algorithm and the number of GA per run were 2,500,000, 
27, 00000 and 50 respectively. All other run parameters were 
maintained at their default settings.  As far as the search methods 
are concerned, we used genetic algorithm only. 
 
Curcumin was obtained from Cambridge structure database (CSD), 
whereas demethoxy curcumin and bis demethoxy curcumin were 
generated  by drawing the 2-D on ChemSketch and 3-D structures 
from CORINA server and optimized with Insight II program 
(Accelrys Inc.). Atomic charges were added using calibration given 
in the AutoDock empirical free energy function and the numbers of 
flexible torsions were defined as seven for all three curcumin Bioinformation   open access 
www.bioinformation.net    Hypothesis
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molecules. To find out hydrogen bonds and hydrophobic 
interactions we used Ligplot [7] and HBPLUS programes [8] that 
automatically generated 2-D diagrams of protein-ligand interactions 
from the 3D coordinates in a PDB file. Ligbuilder [9] program was 
used to design new potent curcumin derivatives and for lead 
optimization i.e.to improve bioactivity by precalculated key site of 
interaction and pharmacophore of the receptor. 
 
 
Figure1: Curcuminoids: (a) Curcumin; (b) Bis-demethoxy curcumin; (c) Demethoxy curcumin          
 
 
Figure 2: (a) Bound conformation of demethoxy curcumin visualized by ADT in the active site of E-chain of TrxR. Curcumin and TrxR 
both molecules are in line model with all interacting residues. (b)  2D representation of 3D structure of [Figure 2 (a)] created with LigPlot. 
[7] The hydrogen bonds were identified with HBPLUS [8] as were the hydrophobic contacts formed between demethoxy curcumin and the 
TrxR residues. Bioinformation   open access 
www.bioinformation.net    Hypothesis
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Discussion: 
TrxR is inhibited by curcumin irreversibly forming an adduct. 
Volume and area of the E and F chains of curcumin binding site 
were simulated by the CASTp program. [10]   Volume of E and F-
chain cavity were 2451 Å
3 and   4996.9 Å
3 respectively, while area 
of both active sites was1437.5 Å2 and 3320.9Å
2. In E chain active 
site 59 amino acid residues and at F chain 135 residues were 
accessible to the solvent. However, twenty-two amino acids are 
common at both the active sites. All the three naturally occurring 
curcuminoids were docked at the active site of E chain whereas the 
docking energies were -9.17 kcal,-9.48kcal,-8.48 kcal, and binding 
energies were -6.75 kcal,-7.17 kcal, -7.0 kcal respectively (Table 1 
in supplementary material). 2D plot of hydrogen bonds and 
hydrophobic interactions of curcumin at the E-chain active site were 
simulated. Four amino acids namely, HIS108(F), ARG351(F), 
LYS29(F) and LEU112(F)  of F chain interact with curcumin 
molecule. Amongst these four F chain residues three are basic 
amino acids. HIS108(F) forms hydrogen bond where ARG351(F), 
LYS29(F) and LEU112(F) are in hydrophobic contacts. The 
continuous stretch of   carboxyl terminal residues of E chain from 
SER495 to GLY499 are important in either hydrophobic or in 
hydrogen bond formation.  SER 483 and TRP467 of E chain are 
also important at the active site. Se atom SeCYS498 residue forms 
hydrophobic contact with C11 atom of curcumin at a distance of 
3.23 Å. Demethoxy curcumin    forms two hydrogen bonds with 
docking energy of -9.48 and binding energy -7.17. Binding of 
demethoxy curcumin   at E chain active site is very precise in 
comparison to curcumin itself [Figure 2(a)]. 2D plot of hydrogen 
bond and hydrophobic interaction of demethoxy curcumin of the E-
chain active site has shown that F-chain does not interact with 
demethoxy curcumin molecule [Figure 2(b)]. The residues ILE478, 
THR481, VAL484, ILE492, GLN494, CYS498 and GLY499 are in 
hydrophobic interactions and the residues SER404, PHE405 
SER483 and GLY496 are involved in hydrogen bond interactions. 
The carboxyl terminal residues of E chain ILE492, GLN494, 
GLY496, SEC498, GLY499 are important in either hydrophobic or 
in hydrogen bond formation. The Se atom of SeCYS498 is at the 
distance of 3.56Å, 3.55 Å and 3.25Å from C13, C12 and C11 
respectively. 
 
 
Figure 3: Key site of Interaction of demethoxy curcumin and Contour map [11] of pharmacophore of the F-chain active site: Simulated by 
ligbuilder programme. [9]
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Bis demethoxy curcumin has only one hydrogen bond with the 
docking energy of -8.84 kcal and binding energy -7.0. Bis 
demethoxycurcumin has shown very poor binding in comparison to 
Curcumin and demthoxy curcumin at same (E chain) active site. 
The 2D plot of hydrogen bond and hydrophobic interaction of 
bisdemethoxy curcumin at the E-chain active site has shown that the 
residue of F-chain does not interact with demthoxy curcumin 
molecule at E-chain active site. The aromatic residues PHE405 
PHE406 TRP407 and SER495 involved in hydrophobic contacts 
and THR481 SER483 GLN494 ILE492 forming hydrogen bond 
with bisdemethoxycurcumin molecule. Bis demethoxy curcumin is 
not as close as curcumin and demethoxy curcumin were to the 
catalytic residues Cys497 and SeCys498 so it can be concluded 
methoxy group is crucial for interaction at E chain active site. All 
the three naturally occurring curcuminoids were also docked at the 
active site of F chain with docking energies -9.75 kcal,-8.13 kcal,-
10.28 kcal, and -7.29 kcal,-9.09 kcal, -8.25 kcal binding energy 
were respectively, Table 2 (see supplementary material). Docked 
conformations of F chain active site and hydrogen bond interaction 
given in the Table 2 (see supplementary material).  The 2D plot 
of Hydrogen bond and hydrophobic interaction of Curcumin-1 at 
the F-chain active site is as shown that the residue of E-chain does 
not interact with curcumin-1 molecule at F-chain active site. Three 
aromatic amino acids, PHE405 PHE406 TRP407, two acidic amino 
acids, GLU477 and ASP491 and two nonpolar amino acid residues 
i.e.VAL484 and ILE492 are involved in hydrophobic interactions. 
GLN494 is crucial for interaction and stabilizes the docked 
conformation by hydrogen bonds. The catalytic residues Cys497 
and SeCys498 do not approach close to the main chain carbon 
atoms of curcumin molecule. Demethoxy curcumin also forms two 
hydrogen bonds with docking energy of -8.13 and binding energy of 
-9.09. The 2D plot of hydrogen bond and hydrophobic interactions 
of demethoxy curcumin at the F-chain active site has been shown 
that TYR106 residue of E-chain forms hydrogen bond with 
demethoxy curcumin molecule at F-chain active site. Three amino 
acids PRO473, HIS472 and GLU477 are involved in hydrophobic 
contacts. Five amino acids viz. LEU409 (F), TYR116(E), 
CYS498(F), GLY499(F) and TRP407(F), form hydrogen bonds 
with demethoxy curcumin and also both hydrophobic interactions 
(at the distance of 3.60Å from  C12 and 3.36Å from C11 atom of  
demethoxy curcumin) and forms hydrogen bond with NH of 
SeCYS498 and O21 of demethoxy curcumin. Bis-demethoxy 
curcumin forms three hydrogen bonds with the docking energy of -
10.28 kcal and the best binding energy -8.25. The 2D plot of 
hydrogen bond and hydrophobic interactions of bisdemethoxy 
curcumin at the F-chain active site has shown that the residues 
CYS59, VAL60 and ILE65 of E-chain interact via hydrophobic 
interactions and SER22 forms hydrogen bond with bis-demethoxy 
curcumin at F-chain active site. Three aromatic amino acids 
PHE405, PHE406 and TRP407 are involved in hydrophobic 
interactions. ILE492 and GLN494 are crucial for interaction and 
stabilizing bis-demethoxy curcumin molecule by hydrogen bonds. 
 
Pharmacophore and receptor based drug designing: 
Since docking at the active site of E chain with curcumin and 
demethoxy curcumin and at F-chain with demethoxy curcumin 
strongly support wet experiment conducted by Fang et al.  [2] 
[concluded by distance mapping Table 3  (see supplementary 
material)]. Hence we did simulation to design and synthesize more 
potent bioactive anticancerous curcumin derivative. In this reference 
we simulated pharmacophore of E-chain active site for curcumin 
and pharmacophore of E and F chain active site for demethoxy 
curcumin. Docking with bis- demethoxy curcumin has not produced 
any significant interaction with the catalytic residues, therefore, bis-
demethoxy curcumin was not considered for further analysis. 
Pharmacophore of E-chain active site with curcumin molecule has 
shown three hydrophobic sites, two hydrogen bond acceptor sites 
and three hydrogen bond donor sites and maximal internal distance 
between two features was 18.63Å. Pharmacophore of E-chain active 
site with demethoxycurcumin have shown two hydrophobic sites, 
two hydrogen bond acceptor sites and four hydrogen bond donor 
sites and maximal internal distance between two points was 15.13Å 
(Figure 3). Pharmacophore of F-chain active site with demethoxy 
curcumin has shown three hydrophobic sites, one hydrogen bond 
acceptor site and four hydrogen bond donor sites and maximal 
internal distance between two points was 11.08 Å.  
 
For de-novo design of ligand all parameters (Lipinski rule and 
ADMET) for drug like molecule were considered. We took 
curcumin as a seed molecule for E chain active site and 
demethoxycurcumin  as a seed for both E and F chain active sites, 
growing points were assigned at OH and OCH3 functional groups in 
all cases. Binding of demethoxy curcumin molecule at E-chain 
active site was quite precise; hence there was no room to add any 
substituent. Whereas curcumin at E-chain active site and demethoxy 
curcumin at F-chain active site have shown big spaces in their 
hydrophobic pockets so a large hydrophobic moiety could be added 
to enhance binding and biological activity. The ligand molecule 
which are being proposed for synthesis are 
Oc2ccc(/C=C/C(O)CC(=O)/C=C/c1ccc(O)c(OC)c1)nc2OC and 
Oc2c(cc(/C=C/C(O)CC(=O)/C=C/c1ccc(O)c(OC)c1)nc2OC)CC all 
being analogs of curcumin  molecule. In our docking simulation 
both chains E and F of thioredoxin reductase were considered 
together because active site resides at both junctions of chains. 
Since Fang et al, reported [3] in their mass spectrometric study that 
it forms 1:2 adduct with Cys-SeCYS residue. Conformation of 
curcumin molecule at the active site of E-chain is important because 
Se atom of SeCYS498 is approaching very close to the Sp2 C-11 of 
main chain of Curcumin molecule. Demethoxycurcumin at both E 
and F chain active sites is showing more interesting results in 
comparison to Curcumin itself. In our docking simulation it is clear 
that demethoxycurcumin molecule is apparently more active than 
curcumin molecule because the interacting Se atom of catalytic 
residue SeCys498 and ligand C atoms are very close to each other in 
both E and F-chain active site. Simulation at the E-chain active site 
with curcumin and demethoxycurcumin shows the latter to be more 
potent while bis demethoxy curcumin is not potent because 
interacting Se atom of receptor and ligand C atom are not as close 
as it is required for binding. Therefore we can conclude that for 
greater binding in the pocket of active site at least one methoxy 
group is necessary [12].  Among all the simulations the demethoxy 
curcumin molecule has been found to be most bioactive. It has 
shown greatest docking energy at the E-chain active site and 
nothing could be added at these functional groups OH, and OCH3. 
While demethoxy curcumin molecule at the F chain active site has 
shown greatest binding energy among all simulations of docking at 
E and F chain active site. Since area and volume of F chain active 
site is greater than E-chain active site so it provides sufficient space 
to add larger substituent at the OCH3   and OH functional group. 
 
Conclusion:  
The present results indicate that synthetic curcumin conjugates 
could be designed and developed as potent anticancer drugs at TrxR 
receptor. Our study has shown that curcumin at the E chain and 
demethoxy curcumin at both E and F chain active sites bind 
strongly as the Se atom is approaching near to C10, C11 or C12 Bioinformation   open access 
www.bioinformation.net    Hypothesis
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carbon atom of curcumin molecule where it is already proved that 
Se atom forms adduct with C13 atom. Therefore, it is possible to 
predict the design of synthetic curcumin derivatives/ conjugates that 
may become more potent anti-cancer drugs, which would be in 
addition to their current anti-cancerous profile. 
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Supplementary material: 
Table 1: Docking energy, binding energy and sites of hydrogen bonds of E-chain active site simulation of TrxR 
     Receptor: Thioredoxin Reductase  (TrxR) E-chain active site  Curcumin lead molecule 
Docking energy   Binding energy  H-bonding 
 
Curcumin 
 
-9.17 Kcal/mol 
 
 
 
-6.75 kcal/mol 
[O(E)SER483H...O24, bond length=2.158 Ǻ] 
[N(E2)HIS108H(F Chain)…O25,   bond length=1.962 Ǻ] 
[NGLY499H…O22, bond length=2.163 Ǻ] 
[NCYS498H…O22, bond length=2.056 Ǻ] 
Demethoxy Curcumin   -9.48 Kcal/mol 
 
-7.17Kcal/mol [NSER483H...O25, bond length =2.154 Ǻ] 
[O24H44...OILE492, Bond length =1.675 Ǻ] 
Bisdemethoxy Curcumin   -8.48 Kcal/mol  -7.0 Kcal/mol  [O21H39...NGLN494, bond length =2.003 Ǻ] 
 
 
Table 2: Docking energy, binding energy and hydrogen bond of E-chain active site simulation. 
eceptor: Thioredoxin Reductase  (TrxR) F-chain active Site   Curcumin lead molecule 
Docking energy   Binding energy  H-bonding 
 
Curcumin-1 
 
-9.75 kcal/mol 
 
-7.29 kcal/mol 
[ O21-H41…OGLN494, bond length =1.818 Ǻ 
[N(E2)GLN494H…O25, bond lenth =2.229 Ǻ] 
Demethoxy Curcumin   
-8.13 kcal/mol 
 
-9.09 kcal/mol 
[O21-H41...NGLY499, bond length =2.129 Ǻ] 
[O25-H45…NLEU409, bond length =1.794 Ǻ] 
 
Bisdemethoxy Curcumin  
 
-10.28 kcal/mol 
 
-8.25 kcal/mol 
[O23-H41...O(D1)ASN419, bond length =2.199 Ǻ] 
[O23-H41...NGLN494,  bond length=2.157 Ǻ] 
[O24-H40...O(OG)SER22(Chain E), bond length =2.026 Ǻ] 
 
Table 3: Distance mapping of the most active conformers of curcuminoids 
Distance between Carbon atom of Curcumin Ligand From Se atom  Common residues at the active site  Docking  
Energy 
Binding  
Energy 
Curcumin-1 at E-chain Active site 
CUR-1  C11  CYS  E  498  SE   3.23 Ǻ CYS-498,GLY-499  -9.17  -6.75 
Curcumin-2 at E-chain Active site 
CUR-2  C13  CYS E 498   SE    3.56 Ǻ 
CUR-2  C12  CYS E 498   SE    3.55 Ǻ 
CUR-2  C11  CYS E 498   SE    3.25 Ǻ 
CYS-498,GLY-499 -9.48  -7.17 
Curcumin-2  at F-Chain Active site 
CUR-2  C12 CYS F 498   SE    3.60Ǻ 
CUR-2  C11  CYS F 498   SE    3.36 Ǻ 
CYS-498,GLY-499 -8.13  -9.09 
 
 
 
 
 
 